Evidence map›Paper›PMID 19361485›Full record

ArticleBiochimica et biophysica acta2009

Computational studies of gramicidin permeation: an entry way sulfonate enhances cation occupancy at entry sites.

Morad Mustafa, Douglas J Henderson, David D Busath

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Morad MustafaDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602, USA. morad.mustafa@gmail.com
Douglas J Henderson
David D Busath
Brigham Young University · US

Funding

DYNAMIC AND STRUCTURAL ELUCIDATION OF GRAMICIDIN A'R01AI023007 · NIAID · FLORIDA STATE UNIVERSITY · PI CROSS, TIMOTHY A · 1987 to 2014
$5.1M
Four Mtb Membrane Proteins: Structure and FunctionR01AI073891 · NIAID · FLORIDA STATE UNIVERSITY · PI CROSS, TIMOTHY A · 2008 to 2012
$2.0M
NIAID NIH HHS AI23007NIAID NIH HHS R01 AI023007NIAID NIH HHS R01 AI073891
6 · The paper itself

Abstract

The impact on the cation-transport free-energy profile of replacing the C-terminal ethanolamine in the gramicidin A channel with a taurine residue is studied using molecular dynamics simulations of gramicidin A (1JNO) embedded in a lipid bilayer (DMPC) with 1 mol/kg NaCl saline solution. The potential of mean force for ion transport is obtained by umbrella sampling. The presence of a negatively charged sulfonate group at the entrance of the gramicidin channel affects the depth and the location of the binding sites, producing a strong attraction for the cations in the bulk. The potential of mean force by the sulfonate acting directly through electrostatics and van der Waals interactions on the test ion is highly modulated by indirect effects (i.e., sulfonate effects on other components of the system that, in turn, affect the ion free-energy profile in the channel). Because the "entry" sites are located symmetrically at both entry and exit of the channel, the deeper free-energy wells should inhibit exit. Given that the channel has increased conductance experimentally, the simulation results suggest that the channel conductance is normally entry limited.

Indexed as

Biological TransportDeuteriumDimyristoylphosphatidylcholineEthanolaminesGramicidinIon ChannelsModels, BiologicalSodiumSulfonic AcidsThermodynamicsWaterDeuteriumDimyristoylphosphatidylcholineEthanolaminesGramicidinIon ChannelsSodiumSulfonic AcidsWater

Identifiers

PMID19361485
PMCPMC2701196
OpenAlexW2047509883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.